Product Information

DURAFLU 325-20-200-60 MG TAB is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.9041 per EA under NDC 50991053501. Its NADAC has been published 311 times since May 18, 2016.

OTC

Strength

325; 20; 200; 60 mg/1; mg/1; mg/1; mg/1

NDC

50991053501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

10/22/2025

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

10/1/2015

Pharmacological Classes

Adrenergic alpha-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for DURAFLU 325-20-200-60 MG TAB has been published 311 times since May 18, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.9041 per EA
All-time high$0.9988 (Mar 14, 2018)
All-time low$0.8919 (Jan 18, 2017)
52-week high$0.9042
52-week low$0.9030
Median price$0.9042
Average price$0.9129
Largest weekly change+11.8% (Feb 21, 2018)
Weeks tracked311
Tracking sinceMay 18, 2016

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.1%

3Y

-0.0%

5Y

-0.0%

All

-0.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DURAFLU 325-20-200-60 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DURAFLU 325-20-200-60 MG TAB, manufactured by Poly Pharmaceuticals, Inc., is $0.9041 per EA (NDC 50991053501), effective Jun 24, 2026.

How has the price of DURAFLU 325-20-200-60 MG TAB changed over time?

Over the history we have for it, the NADAC for DURAFLU 325-20-200-60 MG TAB has held within roughly two percent of its current level. It has been tracked across 311 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for DURAFLU 325-20-200-60 MG TAB?

Since May 18, 2016, the NADAC for DURAFLU 325-20-200-60 MG TAB has ranged from a low of $0.8919 (Jan 18, 2017) to a high of $0.9988 (Mar 14, 2018), with a median of $0.9042 per EA.

Are there cheaper alternatives to DURAFLU 325-20-200-60 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DURAFLU 325-20-200-60 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures DURAFLU 325-20-200-60 MG TAB?

DURAFLU 325-20-200-60 MG TAB (NDC 50991053501) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.